These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7798126)

  • 41. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity?
    Tennison M
    AJNR Am J Neuroradiol; 1999 Jan; 20(1):131-2. PubMed ID: 10348730
    [No Abstract]   [Full Text] [Related]  

  • 42. Antiepileptic efficacy of vigabatrin in people with severe epilepsy and intellectual disability.
    Ylinen A
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():46-9. PubMed ID: 10030432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ACTH versus vigabatrin therapy in infantile spasms: a retrospective study.
    Cossette P; Riviello JJ; Carmant L
    Neurology; 1999 May; 52(8):1691-4. PubMed ID: 10331702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of association between vigabatrin and impaired cognition.
    Monaco F; Torta R; Cicolin A; Borio R; Varetto A; Bergamasco L; Vighetti S
    J Int Med Res; 1997; 25(5):296-301. PubMed ID: 9364292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A risk-benefit assessment of vigabatrin in the treatment of neurological disorders.
    Srinivasan J; Richens A
    Drug Saf; 1994 May; 10(5):395-405. PubMed ID: 8037889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.
    Krauss GL; Johnson MA; Miller NR
    Neurology; 1998 Mar; 50(3):614-8. PubMed ID: 9521245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].
    Vogt H; Krämer G
    Schweiz Med Wochenschr; 1995 Jan; 125(4):125-32. PubMed ID: 7878401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Concentric changes in the visual field associated with GABA-mimetic antiepileptic agents].
    Nordmann JP; Baulac M; Van Egroo C
    J Fr Ophtalmol; 1999 May; 22(4):418-22. PubMed ID: 10365327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New antiepileptic drugs. II. Clinical use.
    Lee BI
    J Korean Med Sci; 1996 Aug; 11(4):289-304. PubMed ID: 8878797
    [No Abstract]   [Full Text] [Related]  

  • 50. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U; Spalice A; Basile LA; Guardalà C; Nasta L; Terenzi S; Iannetti P
    Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group.
    Chadwick D
    Lancet; 1999 Jul; 354(9172):13-9. PubMed ID: 10406359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Symptomatic and asymptomatic visual loss in patients taking vigabatrin.
    Daneshvar H; Racette L; Coupland SG; Kertes PJ; Guberman A; Zackon D
    Ophthalmology; 1999 Sep; 106(9):1792-8. PubMed ID: 10485552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vigabatrin use in psychotic epileptic patients: report of a prospective pilot study.
    Veggiotti P; De Agostini G; Muzio C; Termine C; Baldi PL; Ferrari Ginevra O; Lanzi G
    Acta Neurol Scand; 1999 Mar; 99(3):142-6. PubMed ID: 10100956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of vigabatrin on partial seizures and cognitive function.
    Grünewald RA; Thompson PJ; Corcoran R; Corden Z; Jackson GD; Duncan JS
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1057-63. PubMed ID: 8089668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of clonazepam and vigabatrin in hyperekplexia.
    Tijssen MA; Schoemaker HC; Edelbroek PJ; Roos RA; Cohen AF; van Dijk JG
    J Neurol Sci; 1997 Jul; 149(1):63-7. PubMed ID: 9168167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children.
    Zamponi N; Cardinali C
    Arch Neurol; 1999 May; 56(5):605-7. PubMed ID: 10328256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vigabatrin: placental transfer in vivo and excretion into breast milk of the enantiomers.
    Tran A; O'Mahoney T; Rey E; Mai J; Mumford JP; Olive G
    Br J Clin Pharmacol; 1998 Apr; 45(4):409-11. PubMed ID: 9578192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychotic and severe behavioural reactions with vigabatrin: a review.
    Ferrie CD; Robinson RO; Panayiotopoulos CP
    Acta Neurol Scand; 1996 Jan; 93(1):1-8. PubMed ID: 8825264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A quantitative study of daytime sleepiness induced by carbamazepine and add-on vigabatrin in epileptic patients.
    Bonanni E; Massetani R; Galli R; Gneri C; Petri M; Iudice A; Murri L
    Acta Neurol Scand; 1997 Apr; 95(4):193-6. PubMed ID: 9150807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of new and established antiepileptic drugs.
    Leppik IE
    Epilepsia; 1998; 39 Suppl 5():2-6. PubMed ID: 9737436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.